Literature DB >> 28571163

Utilization Pattern of Potentially Inappropriate Medications in Geriatric Patients in a Tertiary Care Hospital: A Retrospective Observational Study.

Rajal Sudhir Narvekar1, Nikhil Narayan Bhandare2, Jonathan Joaquim Gouveia1, Padma Narayan Bhandare3.   

Abstract

INTRODUCTION: Geriatric population is on the rise throughout the world, hence the quality and the safety of prescribing in the elderly is a global healthcare concern. It is important for the healthcare providers to be aware of the limitations in prescribing certain drugs to the elderly. This study was an attempt to shed light on the utilization pattern of Potentially Inappropriate Medications (PIMs) in elderly patients admitted in the medicine wards in a tertiary care hospital in Goa. AIM: To measure the percentage prevalence of PIMs prescribed in the admitted geriatric patients.
MATERIALS AND METHODS: In this retrospective observational study, 150 case records of patients aged 60 years or more were analysed. All the prescribed medications, for each case record, were then analysed by referring to the American Geriatrics Society (AGS) Beers Criteria 2015. Data was analysed using Statistical Package for Social Sciences (SPSS) software.
RESULTS: Of the 150 patients, 99 (66%) received at least one PIM according to the Beers Criteria 2015 (including drugs to be used with caution). However, after excluding the drugs to be used with caution, the prevalence of PIMs decreased to 44%. The most commonly prescribed PIMs were ranitidine (17.33%) and prazosin (8.66%) and the most commonly prescribed drug to be used with caution was furosemide (35.33%).
CONCLUSION: As the medication needs of the geriatric population are unique, it is essential that the healthcare professionals are aware of these needs and also follow the available guidelines and tools. Formulation of hospital policies and protocols in this regard would help to improve the scenario. Increased education, awareness and reporting of drug-related problems along with more doctor-patient interaction in these situations are some of the factors that could play an important role in promoting better and safer prescribing practices and a better quality of life to the older generations of our communities.

Entities:  

Keywords:  Beers criteria-2015; Elderly; Prescribing pattern

Year:  2017        PMID: 28571163      PMCID: PMC5449809          DOI: 10.7860/JCDR/2017/21080.9731

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  29 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

2.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

Review 3.  Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults.

Authors:  Jeremy Walston; Evan C Hadley; Luigi Ferrucci; Jack M Guralnik; Anne B Newman; Stephanie A Studenski; William B Ershler; Tamara Harris; Linda P Fried
Journal:  J Am Geriatr Soc       Date:  2006-06       Impact factor: 5.562

4.  Irrational drug use in India: a prescription survey from Goa.

Authors:  V Patel; R Vaidya; D Naik; P Borker
Journal:  J Postgrad Med       Date:  2005 Jan-Mar       Impact factor: 1.476

5.  Health care providers' perceptions of the problems and causes of irrational use of drugs in two Middle East countries.

Authors:  S A Otoom; R P Sequeira
Journal:  Int J Clin Pract       Date:  2006-05       Impact factor: 2.503

6.  Variations in injury patterns, treatment, and outcome for spinal fracture and paralysis in adult versus geriatric patients.

Authors:  Zareth N Irwin; Melanie Arthur; Richard J Mullins; Robert A Hart
Journal:  Spine (Phila Pa 1976)       Date:  2004-04-01       Impact factor: 3.468

7.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Authors:  P Gallagher; C Ryan; S Byrne; J Kennedy; D O'Mahony
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

8.  Prevalence of potentially inappropriate medications and prescription cost analysis among older cardiac patients in an outpatient department of a tertiary care hospital in India.

Authors:  Kartik Nitinbhai Shah; Harsh Manishbhai Joshi; Rohan Piyushkumar Christian; Kamlesh Prahaladbhai Patel; Supriya Dipak Malhotra
Journal:  J Basic Clin Pharm       Date:  2016-09

9.  Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital.

Authors:  Joseph O Fadare; Segun Matthew Agboola; Olumide Augustine Opeke; Rachel A Alabi
Journal:  Ther Clin Risk Manag       Date:  2013-03-13       Impact factor: 2.423

10.  Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study.

Authors:  You-Seon Nam; Jong Soo Han; Ju Young Kim; Woo Kyung Bae; Kiheon Lee
Journal:  BMC Geriatr       Date:  2016-06-02       Impact factor: 3.921

View more
  2 in total

Review 1.  Prevalence of drug interactions in hospitalised elderly patients: a systematic review.

Authors:  Luciana Mello de Oliveira; Juliana do Amaral Carneiro Diel; Alessandra Nunes; Tatiane da Silva Dal Pizzol
Journal:  Eur J Hosp Pharm       Date:  2020-02-10

2.  Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis.

Authors:  Akshaya S Bhagavathula; Kota Vidyasagar; Manik Chhabra; Muhammed Rashid; Rishabh Sharma; Deepak K Bandari; Daniela Fialova
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.